The collaboration targets increased awareness of amyloid-related imaging abnormalities monitoring.

Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key ...

On 20 March, at the AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological ...

The West Texas Chapter of the Alzheimer's Association alongside Lubbock Indoor Pickleball are holding a tournament this Saturday, March 28 to benefit Alzheimer's care.

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD) and other ...

Please provide your email address to receive an email when new articles are posted on . Alzheon Inc. has enrolled patients who completed either phase 2 or phase 3 trials to evaluate ALZ-801 as a ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from ...

ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time. The ...